HMD.AX

HeraMED Limited HMD.AX

HMD.AX
HeraMED Limited OSL.AX
OncoSil Medical Limited ENL.AX
Enlitic, Inc. AT1.AX
Atomo Diagnostics Limited NOX.AX
Noxopharm Limited BDX.AX
BCAL Diagnostics Limited IDT.AX
IDT Australia Limited NTI.AX
Neurotech International Limited RHY.AX
Rhythm Biosciences Limited IMC.AX
Immuron Limited

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode HMD.AX OSL.AX ENL.AX AT1.AX NOX.AX BDX.AX IDT.AX NTI.AX RHY.AX IMC.AX
6M 148.28 % -15.25 % -34.00 % 40.00 % 9.41 % -16.84 % -41.00 % -37.04 % 15.38 % 25.00 %
YTD 80.00 % -39.46 % -41.07 % 47.37 % 2.20 % -18.56 % -43.81 % -69.64 % 3.45 % 2.56 %
1Y 44.00 % -64.69 % -48.44 % 27.27 % -19.13 % -31.30 % -52.80 % -66.67 % -18.18 % 3.90 %
3Y -71.69 % -88.96 % -96.12 % -54.84 % -49.73 % 19.70 % -42.31 % -83.81 % -92.04 % -8.05 %
5Y -71.69 % -95.86 % -96.12 % -91.25 % -79.56 % -68.40 % -59.62 % -15.00 % -58.10 % -69.81 %
10Y -79.56 % -96.32 % -96.12 % -92.82 % -43.08 % -68.40 % -83.40 % -93.18 % -67.59 % -85.59 %
From the beginning -79.56 % -97.00 % -96.12 % -92.82 % -43.08 % -68.40 % -95.96 % -93.18 % -67.59 % -98.85 %

Dividend

IDT Australia Limited